JOSE PABLO
MIRAMONTES GONZALEZ
PROFESOR CONTRATADO DOCTOR
![Foto de David](/img/nophoto.png)
David
León Jiménez
Publicacións nas que colabora con David León Jiménez (15)
2022
-
Basal insulin analogues in people with diabetes and chronic kidney disease
Diabetic Medicine, Vol. 39, Núm. 2
2021
-
The influence of diet and probiotics on the response of solid tumours to immunotherapy: Present and future perspectives
Applied Sciences (Switzerland), Vol. 11, Núm. 18
2020
-
Author Correction: A new common functional coding variant at the DDC gene change renal enzyme activity and modify renal dopamine function (Scientific Reports, (2019), 9, 1, (5055), 10.1038/s41598-019-41504-7)
Scientific Reports
-
In response to the paper ‘High-protein diet: A barrier to the nephroprotective effects of sodium-glucose co-transporter-2 inhibitors?’
Diabetes, Obesity and Metabolism
-
Is the joint use of diuretics and SGLT2 inhibitors beneficial in diabetic kidney disease?
Kidney International
2019
-
A new common functional coding variant at the DDC gene change renal enzyme activity and modify renal dopamine function
Scientific Reports, Vol. 9, Núm. 1
-
Could renin-angiotensin-aldosterone system activation explain the amputations associated with canagliflozin? The nitric oxide hypothesis
Diabetes Research and Clinical Practice, Vol. 148, pp. 10-13
-
Diuretic treatment of the patient with diabetes and heart failure. Role of SGLT2 inhibitors and similarities with carbonic anhydrase inhibitors
Revista Clinica Espanola, Vol. 219, Núm. 4, pp. 208-217
-
In response to Yaribeygi et al. "Sodium-glucose cotransporter 2 inhibitors and inflammation in chronic kidney disease: Possible molecular pathways"
Journal of Cellular Physiology
-
Real-life experience with Dulaglutide: Analysis of clinical effectiveness to 24 months
Diabetes Research and Clinical Practice, Vol. 158
-
VEGFR2 and OPG genes modify the risk of subclinical coronary atherosclerosis in patients with familial hypercholesterolemia
Atherosclerosis, Vol. 285, pp. 17-22
2018
-
Diabetes tipo 2 bien contralada y microalbuinuria
Revista Española de Casos Clínicos en Medicina Interna (RECCMI), Vol. 3, Núm. 0, pp. 24-26
-
Reply to 'Effects of sodium-glucose cotransporter 2 inhibitors on urinary excretion of intact and total angiotensinogen in patients with type 2 diabetes' by Yoshimoto et al
Journal of investigative medicine : the official publication of the American Federation for Clinical Research
-
The mechanism of action of sodium–glucose co-transporter 2 inhibitors is similar to carbonic anhydrase inhibitors
European Journal of Heart Failure
-
Update concept of the dual blocking of the renin-angiotensin-aldosteron system. A new therapeutic option?
Medicina Clinica, Vol. 150, Núm. 1, pp. 33-38